Histiocytic Disorders, Malignant
1 clinical trials · Condition
◉ Watch Histiocytic Disorders, Malignant
| Record | Firm | Date |
|---|---|---|
| Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders (NCT04079179) | Carl Allen | 2021-04-19 |
Track Histiocytic Disorders, Malignant automatically
Every clearance here is in the API, with alerts when new ones post.